Rapid risk assessment: Candida auris in healthcare settings – Europe
This rapid risk assessment update appraises the risk for spread of C. auris in hospitals in the European Union and European Economic Area (EU/EEA) countries
EU/EEA capacity for the surveillance of hepatitis B and C using molecular methods
In order to explore whether the current capacity for EU/EEA-wide molecular characterisation for surveillance of HBV and HCV is sufficient to be feasible and what gaps need to be addressed, a survey of EU/EEA Member States was conducted to assess their laboratory capacity and needs in relation to the molecular characterisation of hepatitis B and C.
Candida auris: Epidemiological situation, laboratory capacity and preparedness in European Union and European economic area countries, 2013 to 2017
Kohlenberg, A., Struelens, M.J., Monnet, D.L., Plachouras, D., Apfalter, P., Lass-Flörl, C., Muchl, R., Presterl, E., Willinger, B., Catry, B., Philipova, I., Budimir, A., Hadjihannas, L., Arendrup, M.C., Märtin, P., Jalava, J., Berger-Carbonne, A., Dromer, F., Kurzai, O., Vrioni, G., Kontopidou, F., Kiss, K., Kurcz, A., Ásmundsdóttir, L.R., Burns, K., Moro, M.L., Dimina, E., Valinteliene, R., Perrin, M., Barbara, C., de Greeff, S., Kacelnik, O., Deptula, A., Rodrigues, M.R., Serban, R., Schréterová, E., Stefkovicova, M., Serdt, M., Alastruey-Izquierdo, A., Pemán, J., Byfors, S., Chryssanthou, E., Borman, A., Brown, C., Guy, R., Johnson, E., Reilly, J.
Gap analysis on securing diphtheria diagnostic capacity and diphtheria antitoxin availability in the EU/EEA
This gap analysis demonstrated that there are significant gaps in diphtheria diagnostic capacity within the EU/EEA, with only six Member States fulfilling the minimum criteria in terms of surveillance, specialised laboratory diagnostics and expertise.
CNRL in silico exercise to determine the capabilities of network laboratories to detect triple reassortant swine origin influenza A(H3N2) viruses
Following the emergence of swine influenza A(H3N2) variant (v) viruses with sporadic human infections in North America, the Community Network of Reference Laboratories (CNRL) and the Animal Health and Veterinary Laboratories Agency completed an exercise to assess the CNRL’s capability to detect novel reassortant and circulating triple reassortant swine viruses (TRA) in humans.
EU Laboratory Capability Monitoring System (EULabCap): Report on 2016 survey of EU/EEA country capabilities and capacities
This report for 2016, which presents the indicator results for EU and EEA (European Economic Area) countries, aims to help policymakers identify possible areas for action and to evaluate the impact of capacity strengthening activities and health system reforms.
External quality assessment scheme for Bordetella pertussis serology 2016
This external quality assessment (EQA) to assess the ability of national reference laboratories from EU/EEA Member States to correctly perform laboratory serodiagnostic tests for pertussis was a collaborative study organised from February to April 2016.